News

Lung Function Alone a Poor Marker of Asthma Control in Children


 

FROM THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF ALLERGY, ASTHMA, AND IMMUNOLOGY

SAN FRANCISCO – Lung function alone is a poor marker of asthma control in children, results from a large retrospective analysis demonstrated.

"Physicians should use all components of the 2007 National Asthma Education and Prevention Program Expert Report 3 guidelines, asking questions to patients not only about daytime and nighttime symptoms, but doing lung function testing as well," Dr. Edward K. Hu advised during a poster session at the annual meeting of the American Academy of Allergy, Asthma, and Immunology. "Even [among] those patients who are enrolled in a disease management program, there is still going to be a large minority who are going to be uncontrolled in one way or another, despite follow-up visits and seeing asthma specialists."

Dr. Hu, a fellow in the division of allergy and immunology at the Los Angeles County/University of Southern California Medical Center, Los Angeles, and his associates studied 453 children aged 5-18 years who were enrolled in an asthma management program in Los Angeles County in 2009 and who made a total of 886 follow-up visits. Initial analysis defined asthma control based solely on lung function. Secondary analysis included all components of asthma control based on the 2007 National Asthma Education and Prevention Program Expert Report 3, which included impairment and risk. Of the 453 children, 61% were male and 83% were Hispanic.

At baseline more than one-quarter of patients (29%) had intermittent disease, 21% had mild persistent disease, 25% had moderate persistent disease, and 25% had severe persistent disease.

Dr. Hu reported that when lung function alone was used, 17% of children exhibited asthma that was not well controlled, and 5% exhibited asthma that was poorly controlled. Inclusion of impairment and risk resulted in a downgrade of asthma control in an additional 22% of children.

The researchers also found that males, aged 8-11 years, were significantly more likely than their female counterparts to present with normal lung function and uncontrolled disease due to other factors (24% vs. 15%).

Dr. Hu said that he had no relevant financial disclosures.

Recommended Reading

FDA Cracks Down on Unapproved Prescription Cold, Cough, Allergy Drugs
MDedge Family Medicine
Optimal Lung Resection Therapy Varies by Surgeon Specialty
MDedge Family Medicine
Sublingual Medication Efficacious for Allergic Rhinoconjunctivitis
MDedge Family Medicine
FDA Updates Ambrisentan Label; Monthly Liver Enzyme Tests No Longer Required
MDedge Family Medicine
FDA Revisits Old Issues for COPD Drug Indacaterol at Panel Review
MDedge Family Medicine
FDA Panel: Approve Long-Acting Bronchodilator for COPD
MDedge Family Medicine
Interstitial Lung Abnormalities Linked to Low Lung Capacity, Less Emphysema
MDedge Family Medicine
FDA Panel: Approve Long-Acting Bronchodilator for COPD
MDedge Family Medicine
Study Eyes Nonretrieval Characteristics of IVC Filters
MDedge Family Medicine
Study Finds Preoperative Smoking Cessation Not Harmful
MDedge Family Medicine